logo-crcmlogo-crcmlogo-crcmlogo-crcm
  • Home
  • Our center
    • Introducing the center
    • CRCM support services
    • Our commitments
      • Cellule R6Lab
      • Communication unit
      • CST unit (Thesis Monitoring Committee)
      • Integrity & Scientific Ethics Unit
      • Mentoring unit
      • Parity Professional Equality (PEP)
      • Psychosocial Risks Unit (RPS)
      • Social life unit
      • Animal Welfare Structure (SBEA)
    • Partnerships and Innovation
    • Our scientific network
  • Our research
    • Our research areas
      • Comet Department
      • Genome Integrity Department
      • OHIO Department
      • Translate-it Department
    • Our research teams
    • Our technology platforms
    • CRCM publications
  • For students
    • Studying at CRCM
    • Thesis / Master’s offers
    • Innovative cancer association for students in Marseille (ACIDEM)
    • Mentoring unit
    • News
    • Seminars
  • For scientists
    • News
    • Job offers
    • Seminars
    • Mentoring unit
    • Our alumni
  • Directory
  • The research teams
English
  • French
✕
28 October 2025
28 October 2025

Encapsulating drugs to protect the heart: a major breakthrough against cardiotoxicity

An innovative nano-platform based on dendrimers capable of encapsulating drugs to reduce their cardiac toxicity while improving their therapeutic efficacy.
Do you like it?
Read more
28 October 2025
28 October 2025

The CRCM was featured in a La Provence report on innovative cancer therapies

Jean-Paul Borg discusses the advances made by teams in Marseille in the fields of molecular medicine, immunotherapy and targeted therapies.
Do you like it?
Read more
28 January 2025
28 January 2025

A revolution in pancreatic cancer treatment: the Dusetti / Iovanna team paves the way for personalization

Thanks to the Pancreas-View tool, personalized treatment for pancreatic cancer is becoming a reality. By integrating artificial intelligence and molecular signatures, this tool promises to improve treatment efficacy and patient survival.
Do you like it?
Read more
28 January 2025
28 January 2025

COMBAT-PDAC: The Dusetti / Iovanna team involved in a European project to better understand and treat pancreatic cancer

Pancreatic cancer, one of the most aggressive cancers, is at the heart of the COMBAT-PDAC project, supported by Europe and the ANR. The aim is to personalize treatments using innovative models and identify biomarkers to improve patient survival.
Do you like it?
Read more

Filter by category

  • All categories
  • Comet Department
    • Bard team
    • Lignitto team
    • Borg / Maina team
    • Charafe / Ginestier team
    • Vandermoere team
    • Vasseur / Tomasini team
    • Zimmermann team
  • Genome Integrity Department
    • Gaillard team
    • Coulon team
    • Llorente team
    • Lachaud team
    • Modesti team
    • Pagès team
  • OHIO Department
    • Duprez team
    • Nunès / Devillier team
    • Sepulveda team
    • Aurand-Lions team
    • Chames team
    • Collette / Morelli team
  • Translate-it Department
    • Benzekry / Ciccolini team
    • Bertucci / Mamessier team
    • Dusetti / Iovanna team
    • Pasquier / André team
  • Technology platforms
    • Cytometry
  • CRCM articles
  • Scientific publication
  • Job offers
    • Internship
    • Other opportunities
    • PhD
    • PostDocs

Intranet connection
Directory
IPC Collaboration
News
Events
Partnerships and Innovation
Terms of use
Privacy policy

Marseille Cancer Research Center

27 Bd Leï Roure, CS 30059
13273 Marseille Cedex 09

Tel: 04 86 97 72 00

Contact us How to get here

Follow us

  • YouTube
  • LinkedIn
  • Bluesky
www.crcm-marseille.fr ©2024 | All rights reserved - Created by Yesss communication & Bioself
    English
    • English
    • French
        Manage consent

        To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent or withdrawing consent may adversely affect certain features and functions.

        Learn more

        Functional Always active
        Technical access or storage is strictly necessary for the legitimate interest purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
        Preferences
        Technical access or storage is necessary for the legitimate interest purpose of storing preferences that are not requested by the subscriber or Internet user.
        Statistics
        Storage or technical access that is used exclusively for statistical purposes. Technical storage or access that is used exclusively for anonymous statistical purposes. Absent a subpoena, voluntary compliance from your internet service provider, or additional records from a third party, information stored or retrieved for this sole purpose generally cannot be used to identify you.
        Marketing
        Technical access or storage is necessary to create user profiles in order to send advertisements, or to track the user on a website or across websites with similar marketing purposes.
        Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
        View preferences
        {title} {title} {title}